CytomX Therapeutics (CTMX) Provides Business Update and Outlines 2023 Goals

Go back to CytomX Therapeutics (CTMX) Provides Business Update and Outlines 2023 Goals

CytomX Therapeutics (CTMX) Climbs 50% Following Pact with Moderna on Collaboration for mRNA-Based Conditionally Activated Therapeutics

January 5, 2023 4:37 PM EST

CytomX Therapeutics (NASDAQ: CTMX) Climbs 50% Following Pact with Moderna on Collaboration for mRNA-Based Conditionally Activated Therapeutics

... More